{"data":[{"accessionNo":"0001969223-26-001063","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"Parisotto Shannon M","relationship":"Officer","securityClass":"Common","broker":"UBS Financial Services, Inc","unitsToSell":981,"aggregateMarketValue":308579.64,"unitsOutstanding":47738872,"approxSaleDate":"2026-10-05","exchange":"NYSE","filedAt":"2026-10-05"},{"accessionNo":"0001969223-26-000955","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"FOSTER JAMES C","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":33561,"aggregateMarketValue":10065950.73,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-25","exchange":"NYSE","filedAt":"2026-08-25"},{"accessionNo":"0001969223-26-000932","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"Parisotto Shannon M","relationship":"Officer","securityClass":"Common","broker":"UBS Financial Services, Inc","unitsToSell":2039,"aggregateMarketValue":599710.68,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-19","exchange":"NYSE","filedAt":"2026-08-19"},{"accessionNo":"0001969223-26-000918","issuerCik":"0001100682","issuerName":"Charles River Laboratories International","ticker":"CRL","personName":"Nancy C Andrews","relationship":"Director","securityClass":"Common Stock","broker":"UBS Financial Services Inc","unitsToSell":573,"aggregateMarketValue":163305,"unitsOutstanding":48167730,"approxSaleDate":"2026-08-18","exchange":"NYSE","filedAt":"2026-08-18"},{"accessionNo":"0001969223-26-000886","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"Parisotto Shannon M","relationship":"Officer","securityClass":"Common","broker":"UBS Financial Services, Inc","unitsToSell":3714,"aggregateMarketValue":1038657.24,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-11","exchange":"NYSE","filedAt":"2026-08-11"},{"accessionNo":"0001969223-26-000885","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"Girshick Birgit","relationship":"Officer, CEO & President","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":6500,"aggregateMarketValue":1819350,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-11","exchange":"NYSE","filedAt":"2026-08-11"},{"accessionNo":"0001969223-26-000874","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"FOSTER JAMES C","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":28733,"aggregateMarketValue":7901575,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-10","exchange":"NYSE","filedAt":"2026-08-10"},{"accessionNo":"0001969223-26-000853","issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","personName":"Victoria Creamer","relationship":"Officer","securityClass":"Common","broker":"UBS Financial Services Inc","unitsToSell":4179,"aggregateMarketValue":1086540,"unitsOutstanding":48167730,"approxSaleDate":"2026-08-06","exchange":"NYSE","filedAt":"2026-08-06"},{"accessionNo":"0001969223-26-000852","issuerCik":"0001100682","issuerName":"Charles River Laboratories International, Inc.","ticker":"CRL","personName":"Michael Knell","relationship":"Officer","securityClass":"Common Stock","broker":"UBS Financial Services Inc","unitsToSell":6645,"aggregateMarketValue":1727700,"unitsOutstanding":48167730,"approxSaleDate":"2026-08-06","exchange":"NYSE","filedAt":"2026-08-06"},{"accessionNo":"0001969223-26-000848","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"Parisotto Shannon M","relationship":"Officer","securityClass":"Common","broker":"UBS Financial Services, Inc","unitsToSell":5046,"aggregateMarketValue":1327098,"unitsOutstanding":47738872,"approxSaleDate":"2026-08-05","exchange":"NYSE","filedAt":"2026-08-05"},{"accessionNo":"0001969223-26-000736","issuerCik":"0001100682","issuerName":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","ticker":"CRL","personName":"FOSTER JAMES C","relationship":"Director","securityClass":"Common","broker":"UBS Financial Services, Inc.","unitsToSell":75000,"aggregateMarketValue":16875000,"unitsOutstanding":48167730,"approxSaleDate":"2026-06-29","exchange":"NYSE","filedAt":"2026-06-29"}],"updatedAt":"2026-10-15T14:06:13.408Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}